Intragastric Balloons Market by Product and Geography - Forecast and Analysis 2020-2024

The intragastric balloons market size has the potential to grow by USD 144.87 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by product (insertable balloons and swallowable balloons) and geography (North America, APAC, Europe, South America, and MEA). Also, the report analyzes the market’s competitive landscape. It offers information on several market vendors, including Allurion Technologies Inc., Apollo Endosurgery Inc., Districlass Medical SA, Duomed Group, Endalis, Fengh Medical Co. Ltd., Lexel Srl, Obalon Therapeutics Inc., Silimed, and Spatz FGIA Inc.

Market Overview

Market Competitive Analysis

The intragastric balloons market is concentrated. Increasing preference for minimally invasive techniques will provide ample growth opportunities to market vendors. Fengh Medical Co. Ltd., Lexel Srl, Obalon Therapeutics Inc., Silimed, and Spatz FGIA Inc. are some of the major market participants. Although the cost-effectiveness and safety of intragastric balloon will offer immense growth opportunities, complications associated with intragastric balloon treatment will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this intragastric balloons market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this intragastric balloons market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

• Allurion Technologies Inc.
• Apollo Endosurgery, Inc.
• Districlass Medical SA
• Duomed Group
• Endalis
• Fengh Medical Co. Ltd.
• Lexel Srl
• Obalon Therapeutics Inc.
• Silimed
• Spatz FGIA Inc.

Intragastric Balloons Market: Segmentation by Region

North America was the largest intragastric balloons market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The high prevalence of obesity will significantly influence intragastric balloons market growth in this region.

Over 36% of the market’s growth will originate from North America during the forecast period. The US is the critical market for intragastric balloons in North America. Market growth in this region will be slower than the growth of the market in APAC and Europe.

Intragastric Balloons Market: Segmentation by Product

The insertable balloons segment is the major revenue contributor to the global intragastric balloons market due to the availability of many endoscopically insertable intragastric balloons in the market and its increasing popularity in the developing economies.

Market growth in this segment will be faster than the growth of the market in the swallowable balloons segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the intragastric balloons market size.

Intragastric Balloons Market: Key Drivers and Trends

The cost-effectiveness and safety of intragastric balloons will have a significant influence on market growth. The intragastric balloon implantation procedures are safer and lower cost alternatives to bariatric surgery, which is an invasive weight loss procedure that poses various post-surgical complications. The cost of these procedures is also significantly higher than the intragastric balloon plantation. Hence, there is growing popularity of non-surgical and less-invasive weight loss treatments such as intragastric balloon implantation.

The growing focus of vendors on technological advances, one of the critical intragastric balloon market trends, will also drive market growth. Various leading vendors are focusing on enhancing the capabilities and efficiency of intragastric balloon devices. Manufacturers are also working on the adjustments of the balloon volume and longer implantation time. Minimally invasive procedures are available to implant the intragastric balloon, which can be easily performed in an outpatient set up. An intragastric balloon can be placed through a simple endoscopic method, and it is easily reversible. The advancements in the properties of the intragastric balloon and procedural techniques are influencing vendors to develop innovative and cost-effective products, driving market growth at a CAGR of over 23% during the forecast period.

Intragastric Balloons Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive intragastric balloons market growth during the next five years
• Precise estimation of the intragastric balloons market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the intragastric balloons industry across North America, APAC, Europe, South America, and MEA
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of intragastric balloons market vendors